SEC Form 4 · accession 0000019446-15-000007
CANTEL MEDICAL CORP · CMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles M Diker
Officer — Chairman · Director · 10% Owner
Period of report
Jan 5, 2015
Accepted (ET)
Feb 20, 2015 · 6:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000019446
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.10 per share | Dec 15, 2014 | G | 15,000 | $0.00 | D | 3,348,646 | D | |
| Common Stock, par value $.10 per share | Dec 15, 2014 | G | 3,000 | $0.00 | D | 480,788 | I | By wife |
| Common Stock, par value $.10 per share | Dec 19, 2014 | G | 14,180 | $0.00 | D | 3,334,466 | D | |
| Common Stock, par value $.10 per share | Dec 19, 2014 | G | 3,300 | $0.00 | D | 3,331,166 | D | |
| Common Stock, par value $.10 per share | Dec 19, 2014 | G | 3,300 | $0.00 | D | 477,488 | I | By wife |
| Common Stock, par value $.10 per share | Dec 19, 2014 | G | 2,640 | $0.00 | A | 82,294 | I | By custodial accounts for benefit of grandchildren |
| Common Stock, par value $.10 per shareF1 | Jan 5, 2015 | S | 14,163 | $42.5876 | D | 3,317,003 | D | |
| Common Stock, par value $.10 per shareF2 | Jan 6, 2015 | S | 11,400 | $42.1453 | D | 3,305,603 | D | |
| Common Stock, par value $.10 per shareF3 | Jan 5, 2015 | S | 4,437 | $42.5928 | D | 3,301,166 | D | |
| Common Stock, par value $.10 per share | holding | — | — | — | 234,271 | I | By trust for benefit of children | |
| Common Stock, par value $.10 per share | holding | — | — | — | 29,430 | I | Shares held by Dico Group, Inc. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The per share sale prices ranged from $42.14 to $43.00. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price.
- F2The per share sale prices ranged from $41.40 to $42.65. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price.
- F3e per share sale prices ranged from $42.34 to $42.80. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price.